The video talks about the role of aspirin in acute MI by Dr. Viveka Kumar, Senior Director - Cath Lab, Max Super Speciality Hospital, Saket. Aspirin is a proven and golden drug for acute MI patients and it has been shown to reduce the mortality by 22%. He will also explain that it is the most essential drug in patients who have stent. It is contraindicated in patients who have bleeding complications. In patients with stent, it has to be given at least for a year. Patients who are allergic to aspirin should be given different alternatives.
Dr. Viveka Kumar is a Senior Consultant Interventional Cardiologist and Director of the Cath Lab at Max Super Speciality Hospital in Saket, New Delhi. He completed his MBBS and MD (Medicine) from IMS (BHU), Varanasi and later obtained the DM (Cardiology) postdoc, superspeciality degree through GSVM Medical College, Kanpur. Has extensive experience in the field of Cardiac interventions and Electrophysiology. Specializes in complex angioplasties including multivessel, bifurication and left main angioplasties with Rota Ablation, FFR, IVUS, IABP, IMPELLA devices. Has done more than 7500 angioplasties and 2500 balloon valvotomies with good outcomes.